Invest in Spain is your strategic ally if you are seeking business opportunities and considering investing in Spain.
We are an Executive Board of ICEX-Spain Trade and Investment, a public and business entity of the Ministry of Industry, Trade and Tourism.
Our mission is to promote foreign direct investment (FDI) in Spain and to support business owners and entrepreneurs that want to set up their companies in Spain.
What are our objectives?
- To attract foreign investment - Our goal is to promote, attract and consolidate foreign direct investment in Spain, especially focusing on new investment projects in industry, technology and services.
- To team up with investors - To facilitate collaboration between international investors and Spanish companies that want to expand and develop their activities in Spain.
- To position Spain as a global platform for international business and investments and as an internationalized and competitive economy.
We are working to improve Spain's business climate and appeal as a recipient of foreign direct investments. One of our activities is to propose changes to the regulatory framework in order to make it easier for companies to invest and do business in Spain.
In addition to our HQ in Madrid, we do this through our international network of over 100 economic and commercial offices worldwide.
Meet with ICEX - Invest in Spain and the delegation of Spanish Companies attending as part of the VIP Guest Country Delegation during the 2021 Anglonordic Life Science Conference.
A biopharmaceutical company developing new first-in-class candidates to treat cancer. We are focused on autophagy as a new therapeutic strategy to induce cancer cell death. Based on this novel mechanism of action, we are generating a portfolio of new drugs targeting oncological unmet needs.
Ahead Therapeutics has developed an innovative solution based on the use of PS-liposomes containing auto-autoantigens. Through a biomimetic process, these liposomes can induce antigen specific immune tolerance, thereby interrupting the autoimmune reaction.
Aortyx designs and develops medical devices to cure aortic diseases with the introduction of uniquely designed endovascular patches. Aortyx moves forward from conventional approaches, based on temporary repair, to definitive regeneration.
IOMED is a company located in Barcelona whose main objective is to accelerate clinical research, by helping hospitals to reuse their clinical information.
Leadartis is a biopharmaceutical company engaged in the development of proprietary therapeutic antibodies named Trimerbodies with higher multivalence and multispecificity than the immunoglobulins, which are currently most prevalent on the market.
ISQUAEMIA BIOTECH is a Biotech company focused on development of new pharmacological solutions for CNS pathologies treatment, with first line focused on Stroke.
Marsi-Bionics designs, manufactures and sells modular robotic orthoses for clinical rehabilitation and mobility assistance.
PARKINSONGS is a digital solution in form of a universally accessible APP that offers a therapeutic training method for Parkinson´s patients.